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Image analysis; a novel approach for the quantification of
antineutrophil cytoplasmic antibody levels in patients with
Wegener’s Granulomatosis
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Rises in antineutrophil cytoplasmic antibodies (ANCA) directed against proteinase 3 (PR3)
have predictive potential for a relapse of Wegener's granulomatosis (WG). To assess the
value of image analysis for monitoring ANCA levels, we measured PR3-ANCA in a cohort of
PR3-ANCA positive patients with WG that were prospectively followed in our clinic and
compared findings with other techniques. ANCA levels were measured serially by quantitative
image analysis, titration in indirect immunofluorescence (IIF), two different directly coated
antigen-specific enzyme-linked immunosorbent assays (ELISA), and a capture ELISA using a
PR3-specific monoclonal antibody in 16 consecutive WG patients prior to a renal relapse,
and in 16 age and sex matched patients with inactive WG. The positive predictive value (PPV)
of an increase in ANCA titers by image analysis for relapse was 69% (11 of 16). The PPV of
an increase in ANCA was 61% (11 of 18) by IIF, 71% (12 of 17) by a commercial direct
ELISA, 63% (12 of 19) by in-house direct ELISA, and 75% (12 of 16) by capture ELISA. The
negative predictive value (NPV) of an increase in ANCA titers by image analysis for relapse
was 69% (11 of 16). The NPV of an increase in ANCA was 64% (9 of 14) by IIF, 73% (11 of
15) by a commercial direct ELISA, 63% (9 of 13) by in-house direct ELISA, and 75% (12 of
16) by capture ELISA. In conclusions, quantitative image analysis is a novel technique based
on the principle of IIF to quantify ANCA levels in a single dilution in a patient sample. No
major differences were observed between image analysis and the other techniques in their
capacity to predict relapses of disease activity.
Introduction
Wegener’s granulomatosis (WG) is a systemic disease characterized by necrotizing
granulomatous inflammation of the upper and lower respiratory tract, glomerulonephritis, and
vasculitis (Godman et al., 1954). Prednisolone and cyclophosphamide treatment is very
effective in inducing disease remission in WG (Hoffman et al., 1992). Once remission is
achieved, medication is tapered. The majority of patients, however, experience relapses
during tapering or when treatment has been stopped (Hoffman et al., 1992). Since relapses are
associated with morbidity and mortality (Exley et al., 1997), early detection and prediction of
relapses is of great importance.
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In patients with active WG, anti-neutrophil cytoplasmic antibodies (ANCA) directed against
either proteinase 3 (PR3) or myeloperoxidase (MPO) can be detected in most cases. We have
previously reported that rises in levels of ANCA often precede disease activity, suggesting
that serial measurement of ANCA titers is useful in the follow-up of patients with WG
(Cohen Tervaert et al., 1989; Boomsma et al., 2000). The clinical utility of serial
measurement of ANCA has been studied by several other groups, but the value in monitoring
disease activity remains controversial (Egner et al., 1990; Chan et al., 1993; Kerr et al., 1993;
Davenport et al., 1995; Jayne et al., 1995; Kyndt et al., 1999). A possible explanation for the
observed differences may be technical differences in quantification of ANCA in these studies.
In most of the studies, ANCA were detected by the indirect immunofluorescence (IIF)
technique (Cohen Tervaert et al., 1989; Egner et al., 1990; Chan et al., 1993; Kerr et al., 1993;
Davenport et al., 1995). When the majority of ethanol fixed neutrophils show bright granular
fluorescence of the cytoplasm on fluorescence microscopy, serum titrations are made. The IIF
technique has therefore the disadvantage that levels of ANCA are difficult to quantify (Hagen
et al., 1993; Kerr et al., 1993). Alternatively, antigen-specific enzyme-linked immunosorbent
assay (ELISA) techniques have been used to detect ANCA rises since solid-phase assays that
use purified antigens are better suited to quantify specific antibody levels (Jayne et al., 1995;
Kyndt et al., 1999; Boomsma et al., 2000). In a direct ELISA recognition of the antigen by
antibodies could be hampered by conformational changes in the antigenic proteins induced by
denaturation during coating. In a capture ELISA in which antibodies present the antigen,
conformational changes might be circumvented although relevant epitopes may be blocked by
the capturing antibody. Recently, quantification of ANCA fluorescence levels by image
analysis has been introduced. To assess an accurate quantification of ANCA levels, this
technique which is based on the principle IIF quantitates fluorescence in a single dilution of a
patients sample in comparison to the intensity of standardized calibrators and directly
converting intensity into an antibody titer. Little is known yet about the value of serial
detection and quantification of ANCA by image analysis in order to predict clinical relapse.
To assess the value of quantitative image analysis for measuring ANCA levels in relation to
relapse, we measured ANCA in a cohort of consecutive PR3-ANCA positive WG patients
with a relapse that were prospectively followed in our clinic. To assess the specificity of rises
in ANCA levels for ensuing relapses we also tested samples from matched WG patients
without a relapse. Next, the results obtained by image analysis were compared with data
derived from IIF and different ELISA techniques.
Patients and methods
Patients
Sixteen consecutive patients with WG with a renal relapse (biopsy-proven in 9 patients)
between September 1996 and December 1998 were used for the present study (Boomsma et
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al., 2000). Eligibility required a 12-month disease activity-free period prior to their relapse.
All patients had been positive for PR3-ANCA (Cohen Tervaert et al., 1990) during an active
phase of the disease. The diagnosis of WG was based on the presence of classical symptoms
and histological findings and all patients fulfilled the American College of Rheumatology
1990 criteria for WG (Leavitt et al., 1990) and met the definition for WG of the 1992 Chapel
Hill Consensus Conference (Jennette et al., 1994). Active disease was treated with
prednisolone and cyclophosphamide with or without plasma exchange according to our
standard protocol (Franssen et al., 1998). Recently, a change in the protocol was made and
cyclophosphamide treatment was stopped 3-6 months after induction of remission and
replaced by azathioprine (Jayne et al., 1997). Patients are followed according to a previously
described protocol (Cohen Tervaert et al., 1989; Boomsma et al., 2000). Patients were
evaluated for signs and symptoms of active vasculitis or infections at least every 3 months. At
each visit, blood was collected by venipuncture into EDTA solution, transported on ice, and
centrifuged for 10 minutes at 172 g. Plasma was transferred to a fresh tube and recentrifuged
for 10 minutes at 1655 g to remove platelets. Plasma was stored at -200C until further use.
Complete remission was defined as the complete absence of symptoms or signs attributable to
active vasculitis. A relapse was defined as described previously (Cohen Tervaert et al., 1990;
Stegeman et al., 1994). The study was carried out in accordance with the 1997 Declaration of
Helsinki of the World Medical Association (World Medical Association, 1994).
Samples
A total of 155 samples were investigated. Sixteen plasma samples were obtained from 16
patients at the time of a relapse with renal involvement. In addition, 63 plasma samples
obtained 12, 9, 6 and 3 months prior to the relapse were also used. In one patient with a
relapse, a sample at 6 months prior to relapse was not available. Eighty-one percent of the
patients with a relapse used immunosuppressive medication at entry of the study. At the
moment of relapse, 6 out of 16 patients (38%) were still on (low dose) immunosuppressives.
Seventy-six serial plasma samples matched for the same period of observation and obtained
from 16 age and sex matched patients diagnosed with PR3-ANCA positive WG (11 renal / 5
non-renal), but without a relapse during this period nor within the 12 months following this
period, were used as controls (to test the specificity of rises in ANCA titers). These patients,
14 males and 2 females, aged 61 years (median, range: 28 - 82), had a median (range) of 1
previous relapses (0 - 4). The median (range) period since the previous disease activity
episode was 27 months (3 - 112). In 4 matched patients only 4 instead of 5 samples per
patient were available. Forty-one percent of the matched patients still used
immunosuppressive medication at entry of the study.
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Detection of ANCA by IIF
Classic / cytoplasmic ANCA (C-ANCA) detection by IIF was performed on ethanol-fixed
granulocytes as described previously (Cohen Tervaert et al., 1993). Samples were diluted in
PBS and tested at two-fold serial dilutions starting at 1:20 and ranging up to 1:640. All results
beyond 1:640 are reported as greater than 1:640 (16% of the samples). Slides for ANCA
testing were read independently by two observers who were not informed of the clinical state
of the patient. A titer ≥ 1:40 was considered positive.
Detection of ANCA by quantitative image analysis
Commercial ethanol fixed neutrophil slides and formalin fixed slides were used. Calibrators
with 20, 40, 80, 160, 320 and 640 intensity units and a perinuclear ANCA (P-ANCA) positive
control, a C-ANCA positive control, an antinuclear antibodies (ANA) positive control, and a
negative control were run with each assay. Plasma samples were diluted 1:20 with the kit
dilution buffer. Samples, controls and calibrators were incubated for 30 minutes and washed
with PBS. Polyclonal goat anti human Ig FITC (American Qualex, San Clemente, CA)
conjugate was added at the appropriate dilution and the slides were incubated and washed.
Mounting media was added and cover slips were applied. Slides were then calibrated and read
by the Image analyzer (Roche Image titer system). Values of 20 intensity or more were
considered to be positive units (50 normal controls were negative). All results beyond 640
intensity units were reported as greater than 640 units (<7% of the samples). The intra- and
interassay variations were <5%.
Detection of ANCA by direct ELISA
PR3-ANCA levels were measured using a commercially available direct PR3-ANCA ELISA
kit (Euro-diagnostica, Malmö, Sweden). The assay was performed according to the
manufacturer's instructions with the exception that plasma was used instead of serum.
Samples, diluted 1:50, were measured in duplicate. Using 4 calibrators of 10, 50, 100, and
300 arbitrary units (AU) a calibration curve was prepared. The reference range was supplied
by the manufacturer: values below the calibrator of 10 AU were reported as negative, values
of 10-15 AU were considered borderline positive, and values of more than 15 AU were
considered positive. Samples with values above the calibrator of 300 AU were reanalyzed in a
dilution of 1:500 and results were multiplied by 10. All results beyond 3000 AU were
reported as greater than 3000 AU (<4% of the samples).
In addition, ANCA levels were measured using an in-house ELISA as previously described
(Boomsma et al., 2000). In short, 96-well microtiter plates (Maxisorp; NUNC NS, Roskilde,
Denmark) were coated at 370C for 1.5 hours with 5 mM phenylmethyl-sulphonyl fluoride
(PMSF)-inactivated PR3 (1 µg/ml). After washing, duplicate samples, diluted 1:100, were
incubated for 1 hour at 370C, washed, and incubated with affinity purified F(ab')2 goat anti-
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human IgG conjugated with alkaline phosphatase (dilution 1:3000; American Qualex) for 1
hour at 370C. The plates were developed using P-nitrophenyl-phosphate disodium substrate.
The reaction was blocked by 5 M NaOH, and optical densities were measured at 405 nm. A
standard curve was made using a reference sample included in each test. Values of 6 AU
(mean + 2 SD of 65 normal controls) or more were considered to be positive. Samples with
values above 150 AU were reanalyzed at serial 3-fold dilutions ranging up to 1:2700. All
results beyond 5000 AU were reported as greater than 5000 AU (<7% of the samples).
Detection of ANCA by capture ELISA
PR3-ANCA levels were detected using a commercially available anti-PR3 capture ELISA kit
(Wieslab AB, Lund, Sweden). The assay was performed according to the manufacturer’s
instructions with the exception that plasma was used instead of serum. Values were expressed
as AU. Samples, diluted 1:80, were measured in duplicate. Using 5 calibrators of 10, 40, 80,
160, and 320 AU a calibration curve was prepared. The reference range was supplied by the
manufacturer: values below the calibrator of 10 AU were considered negative, values of 10-
20 AU were reported as borderline positive, and values of more than 20 AU were considered
positive. Samples with values above the calibrator of 320 AU were reanalyzed in a dilution up
to 1:2400. All results beyond 9600 AU were reported as greater than 9600 AU (<10% of the
samples).
Definition of a rise in ANCA
A receiver operating characteristics (ROC) curve was calculated to determine, with optimal
sensitivity and specificity for predicting a relapse, a rise in ANCA as measured by IIF, image
analysis, direct ELISA, and capture ELISA. In an ROC curve, sensitivity versus specificity is
displayed for various cut-off values of rises in ANCA. Each point on the curve represents the
relationship between sensitivity and specificity for a single cut-off value. The numbers along
the curve refer to the cut-off value for each point.
Statistical analysis
To determine differences in levels of serological markers between patients with or without a
relapse in the observed period, the Fischer’s exact test for categorical quantities, and the
Mann-Whitney test (unpaired observations) or the Wilcoxon test (paired observations) were
used when appropriate for continuous quantities. A two-sided P-value of < 0.05 was used to
indicate statistical significance.
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Results
Detection of ANCA in follow-up samples of patients with WG
The clinical characteristics of 16 patients of whom samples prior to and at the time of relapse
were obtained are listed in Table 1. The median (range) BVAS score was 17 (13 - 21).
All 155 samples of 16 patients were tested by the respective techniques. ANCA as detected by
image analysis and IIF were detected in 77 (50%) and 123 (79%) out of 155 samples,
respectively. ANCA as detected by commercial direct ELISA, in-house direct ELISA, and
capture ELISA were detectable in 80 (52%), 145 (94%), and 130 (83%) out of 155 samples,
respectively. Additionally 28 (18%) and 8 (5%) samples were borderline positive when tested
by commercial direct ELISA and capture ELISA, respectively. The concordance between
image analysis, IIF and the ELISA techniques was 71 of 155 samples (46%): 66 with a
(borderline) positive test and 5 with a negative test.
A positive result by image analysis was seen in 12 of 16 (75%) patients with a relapse during
clinical disease activity, whereas a positive result by IIF was seen in 16 of 16 (100%) patients.
Three of four patients with a negative result by image analysis still used immunosuppressives
at the moment of relapse. Using the ELISA technique, 11 of 16 (69%), 15 of 16 (94%), and
16 of 16 (100%) patients with a relapse had detectable ANCA levels during clinical disease
activity when tested by commercial direct ELISA, in-house direct ELISA, and capture
ELISA, respectively. Additionally, 3 of 16 (19%) patients tested borderline positive by
commercial direct ELISA at the time of a relapse. All patients who tested negative for ANCA
in one or more ELISA assays still used immunosuppressives at the moment of relapse. The
concordance between image analysis, IIF and the ELISA techniques was 10 of 16 'active'
samples (63%): 10 with a (borderline) positive test and none with a negative test.
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Table 1 Clinical characteristics of patients with Wegener's granulomatosis at presentation and at relapse of
disease (Median [Range])
Patient at time of relapse
n. 16
Sex, male / female 14 / 2
Age, years 58 [26 - 87]
Mean no. of previous relapses 1 [0 - 12]
BVAS score 17 [13 - 21]
Organ involvement
    Systemic a 81%
    Cutaneous 19%
    Mucous b 25%
    Ear, nose and throat 63%
    Chest 50%
    Cardiac 0%
    Abdominal 0%
    Renal c 100%
    Nervous system 19%
a e.g. fever, arthralgia, myalgia, malaise
b Genital / mouth ulcers or red eyes / proptosis
c Positive biopsy and / or decreased creatinine clearance in combination with proteinuria and erythrocyturia, all
patients had renal involvement because of the inclusion criteria.
Predictive value of changes in ANCA for the occurrence of a relapse
Rises in ANCA levels were related to the occurrence of a relapse in individual patients.
Hereto the size of the increase in ANCA has been based on ROC curves. A rise had to occur
within a period of 3 months. An increase in ANCA was defined as a 4-fold increase in
intensity units for the image analysis (Figure 1A) and an increase in C-ANCA titer was
defined as an increase of at least 2 titer steps (4-fold) for IIF (Figure 1B). An increase in PR3-
ANCA levels as measured by direct ELISA (in-house method and commercial) was defined
as an increase of 50% or more (Figure 1C,D) and an increase in PR3-ANCA levels as
measured by capture ELISA was defined as an increase of 200% or more (Figure 1D). The
results on the basis of these cut-off values are listed in Table 2.
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Figure 1 Receiver operating characteristics curve indicating the detection of increases in antineutrophil
cytoplasmic antibodies (ANCA) by image analysis (fold) (a), indirect immunofluorescence (fold) (b),
commercial direct enzyme-linked immunosorbent assay (ELISA) (%) (c), in-house direct ELISA (%) (d), and
capture PR3 ELISA (%) (e). Each point represents the relationship between sensitivity and specificity of a single
cut-off value (shown as a number beside each point) for the prediction of relapses.
Table 2 Rises in ANCA in relation to the occurrence of relapses in 32 patients with Wegener's granulomatosis
Detection system Rises in ANCA Relapse /
Rise in ANCA
No relapse / No
rise in ANCA
Image Analysis 16 11 / 16 (69%) 11 / 16 (69%)
IIF 18 11 / 18 (56%) 9 / 14 (64%)
Commercial direct ELISA 17 12 / 17 (71%) 11 / 15 (73%)
In-house direct ELISA 19 12 / 19 (63%) 9 / 13 (69%)
Capture ELISA 16 12 / 16 (75%) 12 / 16 (75%)
Commercial plus capture ELISA 20 15 / 20 (75%) 11 / 12 (92%)


















































































































Cross-correlation of the different ANCA detection systems
Since the predictive value of changes in ANCA for the occurrence of a relapse is quite similar
for the different detection systems it is important to know whether these techniques detect
rises in ANCA levels in the same or in different patients. Obviously, if the latter is the case,
combination of techniques might significantly improve the predictive value. There was a
strong association between absolute levels of ANCA as measured by either image analysis,
IIF, two different direct ELISAs, or capture ELISA (Table 3).
Table 3 Cross-correlation of the different detection systems of ANCA levels in samples from 32 patients with
Wegener's granulomatosis
Spearman correlation coefficient





Image Analysis - 0.7179 0.5725 0.5841 0.5870
IIF *** - 0.6973 0.7105 0.7010
Commercial
direct ELISA
*** *** - 0.9688 0.5606
In-house
direct ELISA
*** *** *** - 0.5364
Capture ELISA *** *** *** *** -
Grading of correlation coefficient
ANCA = antineutrophil cytoplasmic antibodies; ELISA = enzyme linked immunosorbent assay; IIF = indirect
immunofluorescence; *** = Spearman correlation P ≤ 0.001.
Regarding rises in ANCA (Table 4a,b), overall concordance between all detection systems
was noted in only 10 out of 32 patients (31%). Five out of 16 WG patients (31%) with a
relapse showed a rise in ANCA in all ANCA detection assays whereas the remaining 11
patients showed a rise by 2 or more different ANCA detection assays. Four out of 16 WG
patients (25%) without a relapse showed no rise in any of the ANCA detection assays,
whereas the remaining 12 patients (75%) showed a rise by 1 or more different ANCA
detection assays. Only one of these 12 patients showed a rise in all ANCA detection assays.
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A positive effect on the predictive value was only obtained by the combination of the
commercial direct ELISA and the capture ELISA (Table 3). Using this combination 15 of 16
patients (94%) with a relapse were identified by a rise in ANCA as compared to 12 of 16
(75%) (commercial ELISA alone) and 12 of 16 (75%) (capture ELISA alone). Four of 16
patients (25%) without a relapse were (falsely) identified by a rise as compared to 4 of 16
(25%) (commercial ELISA alone) and 3 of 16 (19%) (capture ELISA alone). The percentage
of patients with a rise in ANCA that experienced a relapse was 75% (15 of 20) (commercial
plus capture ELISA) as compared to 75% (12 of 16) (capture ELISA alone) and 71% (12 of
17) (commercial ELISA alone). The percentage of patients with no rise in ANCA that did not
experience a relapse increased to 92% (11 of 12) (commercial plus capture ELISA) as
compared to 75% (12 of 16) (capture ELISA alone) and 73% (11 of 15) (commercial ELISA
alone).












1. 59 M - 1,2 - 1,2 2
2. 72 M 1 1,2 1,4 1,2,4 1,2,3
3. 71 F 3 - 2,3 1,2,3,4 -
4. 33 M 1 1 1,2 1 1
5. 45 M 1 1 1 1 1
6. 53 M 4 4 1 1,2,4 -
7. 50 M 2,3 3 2,3,4 2,3,4 2,3
8. 26 F 4 - - - 4
9. 87 M 1,4 3 2 - -
10. 70 M 3 - - 3 -
11. 74 M 1 2 1,3 1,3 3
12. 51 M - 1 - - 1
13. 49 M - 1,3 1,3 1,3,4 1
14. 59 M - 1,2 1 1,2 1
15. 57 M 4 - 1,4 - 4
16. 68 M - - 3 1,3 3
ANCA = antineutrophil cytoplasmic antibodies; F = female; M = male; - = no rise in ANCA; 1 = rise in ANCA
at the moment of relapse; 2 = rise in ANCA 3 months prior to relapse; 3 = rise in ANCA 6 months prior to




Table 4b Characteristics rise in ANCA rises during a followup of 12 month in 16 age and sex matched patients











1. 67 M - 1 1 - 1
2. 41 M - - - - -
3. 32 M 3 - 1 1 -
4. 63 M - - - 2 -
5. 66 M 3 - - 2 -
6. 28 F 2 - - - -
7. 59 M - 2 - 3 -
8. 46 M - - - - -
9. 60 M - 3 2,4 2,4 4
10. 70 M - - - - -
11. 78 M - - - - -
12. 38 M - 3 - - -
13. 81 F 1,2 1 1 1 1
14. 41 M 4 - - - -
15. 82 M - 1 1 1 1
16. 79 M - 2 - - -
ANCA = antineutrophil cytoplasmic antibodies; F = female; M = male; - = no rise in ANCA; 1-4 = Rise in
ANCA within the 1st, 2nd, 3rd, and/or 4th quartile of the matched period; ELISA = enzyme linked
immunosorbent assay; IIF = indirect immunofluorescence.
Discussion
Quantification of ANCA titers is important for monitoring patients with WG since increases
in ANCA levels may predict relapses of disease activity. For the quantification of ANCA
titers two different techniques have been applied, i.e. IIF and antigen specific ELISA. A major
difference between these two techniques is that for IIF ethanol fixed neutrophils are being
used as substrate for autoantibody binding, whereas ELISA makes use of highly purified
antigens. Therefore, discrepancies between data obtained by either IIF or ELISA may be
explained by the fact that IIF enables the detection of autoantibodies with specificity for a
variety of neutrophil constituents. In the present study we present a novel approach for the
quantitative analysis of ANCA. The image analysis technique, which is based on the IIF
technique, offers a clear advantage with respect to quantification. Whereas ANCA
quantification by the IIF technique requires serum titration, ANCA levels are quantified in a
single serum dilution by image analysis. Assaying multiple dilutions of sera by IIF is time
consuming and prone to observer variability. Image analysis offer the possibility of achieving
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reproducible quantitative results (like the ELISA technique) combined with the ability to
detect autoantibodies with specificity for a variety of neutrophil constituents (unlike the
ELISA technique). We have compared this novel technique with the IIF and ELISA
technique. Hereto we have evaluated findings in a cohort of consecutive PR3-ANCA positive
WG patients with a relapse that were prospectively followed in our clinic, in comparison to
matched WG patients without a relapse.
Evaluation of the image analysis techniques for the potential to detect ANCA in the samples
under investigation in the current study revealed that in 75% of the patients ANCA levels
were detectable by image analysis technique at the time of a renal relapse. These results
suggest a lower diagnostic sensitivity as compared to IIF (100%) and the capture ELISA
(100%). It has been demonstrated that the use of a capture ELISA is the preferred method to
detect ANCA for diagnosis of disease (Basland et al., 1995; Westman et al., 1998). However,
the present study was not designed to determine sensitivity of the different techniques at the
moment of diagnosis.
With respect to the positive predictive value of ANCA detection by image analysis we found
that rises in ANCA are followed by a relapse in the majority of WG patients (69%). The
positive predictive value (PPV) of ANCA measurement by quantitative image analysis for
predicting relapses is therefore somewhat better than by IIF (56%) and comparable to the
direct ELISA technique (commercial: 71%, in-house: 63%). We previously demonstrated that
measuring PR3-ANCA by our in-house direct ELISA (PPV: 59% within 12 months, 71%
during longer follow-up) is superior to measuring C-ANCA by IIF (PPV: 50% within 12
months, 57% during longer follow-up) for the prediction of an ensuing relapse (Boomsma et
al., 2000). Our present findings are in line with the previous results although comparing the
results of the latter study with those of the present study remains difficult due to substantial
differences in study design and size. The predictive value of rises in PR3-ANCA as detected
by capture ELISA has not been studied prospectively so far. Although statistical analysis is
not appropriate due to the size of the present study, the capture ELISA seems to perform
somewhat better with respect to predictive value for relapse of disease activity. Combination
with the test that performs second best, i.e. the commercial direct ELISA, even further
improves the predictive value of the capture ELISA. Obviously, the latter option is associated
with higher workload and costs.
In conclusion, we found that ANCA levels measured by image analysis is a new and
promising technique to follow the course of disease in patients with Wegener's
granulomatosis. Furthermore, there is a strong association between ANCA titers as measured
by image analysis, IIF, direct ELISA, and capture ELISA. The predictive value of ANCA
measurement by quantitative image analysis for predicting relapses is somewhat better than
IIF, but comparable to direct ELISA. From this study, it is suggested that the capture ELISA
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